Zuari agro chemicals Limited has entered into a settlement agreement with the Securities and Exchange Board of India (SEBI) to resolve allegations of regulatory violations. The company disclosed the settlement through an official intimation to stock exchanges on March 06, 2026.

Settlement Details and Financial Impact

SEBI issued Settlement Order No. SO/AK/GN/2025-26/8384-8388 dated March 05, 2026, following settlement applications filed by both the company and Director Mr. Nitin M. Kantak. The settlement covers multiple alleged violations spanning various SEBI regulations.

Alleged Violations by the Company

The settlement addresses multiple regulatory breaches by Zuari Agro Chemicals Limited across different SEBI frameworks:

SEBI Listing Obligations Violations:

• Regulations 4(1)(a), (b), (c), (d), (e), (g), (h), (i), (j)
• Regulations 4(2)(e)(i), 23(2), 23(4), and 48
• Violations read with Indian Accounting Standard – 8

Fraudulent Trade Practices Violations:

• Section 12A (a), (b), (c) of SEBI Act 1992
• Regulations 3(b), (c), (d), 4(1), 4(2)(f), (k) of SEBI Prohibition of Fraudulent and Unfair Trade Practices Regulations, 2003

Director's Regulatory Breaches

Mr. Nitin M. Kantak, Director of the company, faced separate allegations under:

• Regulations 23(2) and 23(4) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015
• Section 27 of SEBI Act, 1992

The Director filed a separate settlement application (No. 8387/2025) under the SEBI Settlement Proceedings Regulations, 2018.

Operational and Financial Consequences

The settlement carries significant financial and operational implications for the company. Zuari Agro Chemicals has paid the settlement amount of ₹1,19,92,500 and voluntarily accepted a 3-month debarment from buying, selling, or trading in the securities market.

The company received the settlement order via email on March 05, 2026, and promptly disclosed the information to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Zuari Agro Chemicals has released its Q3 consolidated financial results, revealing a challenging performance with significant declines across key financial metrics compared to the same quarter in the previous year. The agrochemicals company faced substantial headwinds during the quarter, reflected in its profitability and operational efficiency indicators.

Financial Performance Overview

The company's Q3 consolidated financial performance showed significant deterioration across all major metrics:

| Metric: | Q3 Current Year | Q3 Previous Year | Change || | ---: | :--- | :--- | :--- | | Net Profit: | 397 million rupees | 545 million rupees | 27% Decline | | Revenue: | 3.4 billion rupees | 12.6 billion rupees | 73% Decline | | EBITDA: | 90 million rupees | 1.16 billion rupees | 92% Decline | | EBITDA Margin: | 2.62% | 9.2% | 660 bps Decline |

EBITDA Performance Analysis

The most striking aspect of Zuari Agro Chemicals' Q3 results was the dramatic decline in EBITDA performance. The company reported EBITDA of 90 million rupees compared to 1.16 billion rupees in the corresponding quarter of the previous year, representing a steep 92% year-on-year decline. This substantial reduction highlights the severe operational challenges faced by the company during the quarter.

Margin Compression

The EBITDA margin contracted significantly to 2.62% in Q3 from 9.2% in the year-ago period, indicating a compression of 660 basis points. This margin deterioration reflects the company's struggle to maintain operational efficiency and cost management amid challenging business conditions. The sharp margin decline suggests that costs increased disproportionately relative to revenue generation.

Revenue and Profitability Impact

Zuari Agro Chemicals reported a consolidated net profit of 397 million rupees for Q3, down from 545 million rupees in the corresponding quarter of the previous year, marking a 27% year-on-year decline. The revenue figures showed an even more pronounced decline, dropping to 3.4 billion rupees from 12.6 billion rupees in the year-ago period, representing a 73% decline. This significant reduction in top-line performance, combined with the EBITDA decline, indicates comprehensive operational challenges across the business.

Market Context

The results reflect a particularly difficult quarter for Zuari Agro Chemicals in the agrochemicals sector. The combination of revenue decline, margin compression, and EBITDA deterioration suggests the company faced multiple headwinds including market conditions, operational inefficiencies, or sector-specific challenges that significantly impacted its financial performance during the reporting period.